Paweł Syska

ORCID: 0000-0003-3241-5609
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias
  • Cardiomyopathy and Myosin Studies
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Structural Anomalies and Repair
  • Cardiac Valve Diseases and Treatments
  • Neurological disorders and treatments
  • Infective Endocarditis Diagnosis and Management
  • Cardiovascular Effects of Exercise
  • Heavy Metal Exposure and Toxicity
  • Cardiovascular and exercise physiology
  • Innovation Policy and R&D
  • Neuroscience and Neural Engineering
  • Medical Imaging Techniques and Applications
  • ECG Monitoring and Analysis
  • Advanced Radiotherapy Techniques
  • Viral Infections and Immunology Research
  • Cardiac Arrest and Resuscitation
  • Pharmaceutical Economics and Policy
  • Global Health Care Issues
  • Brain Metastases and Treatment
  • Mechanical Circulatory Support Devices
  • Iterative Learning Control Systems
  • Polish Legal and Social Issues

Institute of Cardiology
2016-2025

Corona (Poland)
2010-2018

Centralny Szpital Kliniczny
2018

Cardinal Stefan Wyszyński University in Warsaw
2017

Having several recently published reports on increased rate of cardiac perforation with some lead models as background, we assess the relation between perforations and leads used.All pacing defibrillation implantations 1 January 2007 31 March 2008 were analysed retrospectively. There 2247 implanted in 1419 patients aged 67.6 +/- 14.1, 1200 (53%) active 1047 (47%) passive fixation leads. Cardiac occurred eight (0.5%). The number does not differ significantly pacemaker implantable cardioverter...

10.1093/europace/eun363 article EN EP Europace 2008-11-04

ICD in Hypertrophic Cardiomyopathy Patients. Introduction: Although implantable cardioverter‐defibrillators (ICDs) are used sudden cardiac death (SCD) prevention high‐risk patients with hypertrophic cardiomyopathy (HCM), long‐term results as well precise risk stratification discussed a limited number of reports. The aim the study was to assess incidence intervention HCM relation clinical profile. Methods and Results: We studied 104 consecutive implanted single center. mean age population...

10.1111/j.1540-8167.2009.01716.x article EN Journal of Cardiovascular Electrophysiology 2010-02-01

The aim of the study was to assess clinical efficacy antazoline, a first-generation anti-histaminic agent, in rapid conversion paroxysmal non-valvular atrial fibrillation (AF) sinus rhythm patients without heart failure.This single center, randomized, double blind, placebo-controlled, superiority trial. We enrolled with an AF episode lasting less than 43 h, stable cardiopulmonary condition. Subjects who fulfilled selection criteria were randomly assigned receive intravenously either placebo...

10.1093/europace/euw384 article EN EP Europace 2016-11-02

The aim of this European Heart Rhythm Association (EHRA) prospective snapshot survey is to assess peri-procedural practices, implantation techniques, and short-term procedure-related complications associated with subcutaneous implantable cardioverter-defibrillator (S-ICD) or transvenous (TV-ICD), across tertiary electrophysiology centres. An internet-based electronic questionnaire concerning settings, routines, personnel, complications, patient outcomes was sent the centres routinely...

10.1093/europace/euy092 article EN EP Europace 2018-05-11

Young implantable cardioverter-defibrillator (ICD) recipients present a high rate of inappropriate interventions. Some them are caused by suboptimal pre-discharge programming the device. There conflicting data as regards antitachycardia pacing (ATP) effectiveness in children and young adults. We report our experience with ICD complications during 10 year follow-up.We analysed use ATP 63 patients aged 6-21 years. Antitachycardia (burst or ramp) was programmed ON 14 (22%), 49 (78%) had only...

10.1093/europace/euq263 article EN EP Europace 2010-07-21

Ensuring a haemodynamically effective cardiac rhythm is challenge in patients waiting for pacemaker reimplantation after transcutaneous lead extraction due to an infection of the implanted system.The authors report retrospective analysis temporary pacing with active fixation (AFTP) connected externalised transvenous (TLE) infection.AFTP was used 34 (12 women) aged from 38 88 years (mean 67.5 years). This represented 24.5% population undergoing TLE infective indications. In 32 cases,...

10.5603/kp.a2015.0093 article EN cc-by-nc-nd Kardiologia Polska 2015-05-19

Background: The use of subcutaneous implantable cardioverter-defibrillators (S-ICD) has been growing in Poland since 2014. Polish Registry S-ICD Implantations was run by the Heart Rhythm Section Cardiac Society between May 2020 and September 2022 to monitor implementation that therapy Poland. Aims: To investigate present state-of-the-art implantation Methods: Implanting centers reported clinical data patients undergoing implantations replacements, including age, sex, height, weight,...

10.33963/kp.a2023.0046 article EN Kardiologia Polska 2023-05-29

Background: Antiarrhythmic treatment of patients with recurrent ventricular tachyarrhythmia, in whom catheter ablation and amiodarone were ineffective or contraindicated, is an unsolved clinical problem. Aim: The study aims to evaluate the efficacy tolerability mexiletine tachyarrhythmias and/or electrical storm events, standard strategies failed prevent tachyarrhythmia. Methods: We performed a retrospective cohort analysis all treated for tachycardia fibrillation our institution between...

10.5603/kp.2017.0189 article EN cc-by-nc-nd Kardiologia Polska 2017-10-18

The increasing number of patients with cardiac implantable electronic devices (CIEDs) causes a rise in the absolute percentage individuals qualifying for transvenous lead extraction (TLE) due to infectious, vascular or failure related indications. As survival time prolongs, TLE procedures more and often concern electrodes long- -term functioning. Authors provide retrospective analysis effectiveness safety performed on leads implanted at least 10 years before extraction.Between 2008 2012 we...

10.5603/cj.a2013.0143 article EN Cardiology Journal 2013-10-21

Abstract Background Young implantable cardioverter defibrillator ( ICD ) recipients have a high rate of complications, some which seem to be underestimated. We report our clinical experience with therapy in children and young adults during 15 year follow up. Methods reviewed the database at present institution chose 73 consecutive patients who underwent implantation age 6–21 years. analyzed intervention rate, mortality, characteristics complications treatment options. Results A total 20/73...

10.1111/ped.13660 article EN Pediatrics International 2018-07-12

The only subgroups of patients with heart failure and atrial fibrillation in which the efficacy cardiac resynchronization therapy has been scientifically proven are indications for right ventricular pacing after atrioventricular junction ablation. However it is unlikely that ablation would be a standard procedure majority concomitant due to irreversible character spontaneous sinus rhythm resumption occurs about 10% these patients. Pilot-CRAfT first randomized controlled trial evaluating...

10.1186/1745-6215-15-386 article EN cc-by Trials 2014-10-04

Background: Over the last several years evolution of transvenous implantable cardioverter‑defibrillator (T‑ICD) system and introduction subcutaneous ICD (S‑ICD) have contributed to development sudden cardiac death (SCD) prevention in clinical practice. Aims: To report our experience with therapy children young adults during twenty‑ ‑two follow‑up. Methods: We reviewed database recipients choosing 80 consecutive patients (pts) implanted at age 6–21 1996–2018. analyzed rate appropriate (AT)...

10.33963/kp.15469 article EN Kardiologia Polska 2020-07-02

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Kuśmierski K, Syska P, Maciąg A, Oręziak Kuśmierczyk M, Przybylski A. Original paperRegaining venous access for implantation of a new lead. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2013;9(1):16-21. doi:10.5114/pwki.2013.34025. APA Kuśmierski, K., Syska, P., Maciąg, A., Oręziak, Kuśmierczyk, M., & Przybylski, (2013). Interwencyjnej, 9(1), 16-21....

10.5114/pwki.2013.34025 article PL cc-by-nc-sa Advances in Interventional Cardiology 2013-01-01

Background: Still increasing life expectancy in patients with implanted devices and large number of leads more often induce the need to cure treatment complications or change especially cardiac resynchronization therapy (CRT). In order prevent further complications, possibility damaged redundant extraction should be taken into consideration. The aim paper was assess effectiveness safety transvenous lead (TLE) co-implantation systems. Methods results: Between 2008 March 2013, system removal...

10.5603/cj.a2014.0064 article EN Cardiology Journal 2015-04-28

Transvenous lead extraction (TLE) is recommended in cases of local and systemic infections related to cardiac implantable electronic devices (CIEDs). Additionally, TLE indicated the event damage or CIED malfunction. The procedure associated with a risk life-threatening complications.The aim EVO registry was assess safety efficacy birotational Evolution tool usage.This study prospectively conducted 8 high-volume implantation centers Poland. included 133 patients aged 63.5 ±15.1 years, 76.69%...

10.17219/acem/161961 article EN cc-by Advances in Clinical and Experimental Medicine 2023-04-19

AMA Przybylski A, Syska P, Oręziak et al. Original paperUsefulness of the Evolution mechanical dilator sheath for endocardial lead extraction – preliminary results. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2010;6(2):59-65. doi:10.5114/pwki.2010.14164. APA Przybylski, A., Syska, P., Oręziak, Maciąg, Steriński, M., & Kuśmierski, K. (2010). Interwencyjnej, 6(2), 59-65. https://doi.org/10.5114/pwki.2010.14164 Chicago Andrzej, Paweł Artur Aleksander Maciej...

10.5114/pwki.2010.14164 article PL cc-by-nc-sa Advances in Interventional Cardiology 2010-01-01
Coming Soon ...